Vascular Biogenics Ltd. Skyrocketed
Vascular Biogenics Ltd. (VBLT:NASDAQ) rocketted at $0.17, a gain of 29.5%. On Thu, Feb 23, 2023, VBLT:NASDAQ touched a New 2-Week High of $0.17. The stock got featured on our News Catalysts scanner on Thu, Feb 23, 2023 at 07:34 AM in the 'AGREEMENT' category. From Thu, Feb 09, 2023, the stock recorded 22.22% Up Days and 10.00% Green Days
The stock spiked on Thu, Feb 23, 2023 at $0.25 with a volume of 153M+.
About Vascular Biogenics Ltd. (VBLT:NASDAQ)
Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.
Top 10 Gainers:
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 124.53%
- Genesis Growth Tech Acquisition Corp. (GGAA:NASDAQ), 63.94%
- Atlas Lithium Corporation (ATLX:NASDAQ), 60.47%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 43.2%
- Expion360 Inc. (XPON:NASDAQ), 42.39%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 34.69%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.91%
- Vascular Biogenics Ltd. (VBLT:NASDAQ), 29.46%
- Verde Clean Fuels Cl A (VGAS:NASDAQ), 28.15%
- Elevation Oncology Inc. (ELEV:NASDAQ), 27.27%